Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,490
Closed -$4.72M 4896
2025
Q4
$4.72M Sell
37,490
-439
-1% -$57.3K 0.01% 814
2025
Q3
$5.55M Sell
37,929
-66,466
-64% -$10M 0.02% 642
2025
Q2
$16.3M Buy
104,395
+82,686
+381% +$13.1M 0.07% 184
2025
Q1
$3.57M Sell
21,709
-35,231
-62% -$5.86M 0.02% 576
2024
Q4
$9.28M Buy
56,940
+447
+0.8% +$79.9K 0.05% 250
2024
Q3
$11M Buy
+56,493
New +$10.4M 0.05% 222
2024
Q2
Sell
-5,253
Closed -$888K 3251
2024
Q1
$888K Buy
+5,253
New +$984K 0.01% 944
2023
Q1
Sell
-89,902
Closed -$13.2M 3308
2022
Q4
$13.2M Buy
89,902
+76,763
+584% +$11.4M 0.19% 99
2022
Q3
$1.95M Buy
+13,139
New +$2.2M 0.02% 612
2022
Q2
Sell
-206,693
Closed -$39M 3870
2022
Q1
$39M Buy
+206,693
New +$40.9M 0.28% 41
2020
Q2
Sell
-10,446
Closed -$1.23M 1810
2020
Q1
$1.23M Buy
+10,446
New +$1.38M 0.08% 222
2018
Q3
Sell
-5,440
Closed -$463K 520
2018
Q2
$463K Buy
+5,440
New +$459K 0.17% 111

Other funds holding ZTS

HRT Financial's ZTS Position: Q1 2026 in Review

HRT Financial sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 37,490 shares — an estimated $4.72M sold.

HRT Financial first reported a position in ZTS in Q2 2018 and held it in 12 quarters. The position peaked at $39M in Q1 2022. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • HRT Financial reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 37,490 Zoetis shares in Q1 2026, an estimated $4.72M.
  • HRT Financial first reported a position in Zoetis in Q2 2018 and held it in 12 quarters.
  • HRT Financial's Zoetis position peaked at $39M in Q1 2022.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.